News Focus
News Focus
Followers 85
Posts 3036
Boards Moderated 0
Alias Born 09/07/2014

Re: brazen22 post# 806232

Thursday, 01/01/2026 3:57:10 PM

Thursday, January 01, 2026 3:57:10 PM

Post# of 818509
Brazen, I wrote;

I want to counter Brazen's post which mostly put all the blame on the time it's taken to bring DCVax to commercialization smack on the company. There are several reasons why it's taken a long time, and bashers posting outright lies and cutting down the company with no facts - or facts they've helped create - are very, very much a part of the problem.



I was making an argument to your statement:

Glioblastoma is a devastating disease, and the need for better treatments is unquestionable. But none of the issues being discussed here are created by posters. Message-board commentary does not determine or hinder approvals, filings, or outcomes. Those decisions rest entirely with the company. If there are concerns about delays, regulatory strategy, or progress, they ultimately belong with NWBO’s management — not with people asking questions or raising concerns.



Here is where I stand on your comments:

1Glioblastoma is a devastating disease, and the need for better treatments is unquestionable. Absolutely

2)But none of the issues being discussed here are created by posters. I totally disagree, which is why I wrote what I wrote because I believe that BASHERS are holding our price down, and the company suing the 7 MMs gives my comment credibility.

3) Message-board commentary does not determine or hinder approvals, filings, or outcomes.
I disagree with this statement of yours. We can all do math, and everyone here knows that it's harder to pay for a multi-million dollar potential cure for cancer when BASHERS have driven your share price down to pennies for 10 years.

4)Those decisions rest entirely with the company.
It's difficult to raise the money you need to

improve, recreate, discover, or invent most of the technology needed to truly commercialize DCVax.

if I can quote myself. I gave you a few facts that show this happened. There's a ton more that you can look up.

5) If there are concerns about delays, regulatory strategy, or progress, they ultimately belong with NWBO’s management — not with people asking questions or raising concerns.
Again, it's all about money, isn't it? And BASHERS have failed to do their job, which was to kill a life-saving or life-extending treatment for cancer.
Do you have a problem with that statement, Brazen? Do you think there is no proof of DCVax saving lives? You're the poster who suggested Brad Silver didn't know what he was talking about when he credited DCVax with saving his life. XMaster wrote:

Monday, October 14, 2024 4:45:38 PM
Post# of 806240
Google Brad Silver. “DC-Vax saved my life, gave me the ability to continue to be a husband, father, coach and a friend."
Please call Brad and tell him he’s wrong.

And you responded: Brad had surgery to remove the tumor prior to receiving dcvax. So, which one really worked?
So, what's the difference between Brad Silver and everyone else who got GBM back then when Dr. Liau was doing her initial clinical trials with DCVax? The difference was everyone else died. Then there was Brad Silver, who received DCVax. But he had the bad(?) luck of having the fastest and most deadly gene-type, which had a death rate hovering around 100%. And he lived. Over 20 years and is still alive. That's a fact. As XMaster suggested, "go call Brad Silver." Why do I know this is a fact about Brad's gene-type? Because I took the time to read Dr. Liau's scientific, published paper on DCVax's initial clinical trials and many others that she wrote. She was shocked.


I'll leave you with one last fact to mull:
Did you read the 2022 Q&A with Dr. Liau from Dr. Mueller (sp) that was just released on X?
In it Dr. Liau points to about 62 long-term survivors (as of 2022 when some had not even entered the Ph III trial long enough to be 5-year survivors). But one of those trials were patients actually removed from the main PH III trial because they had one of many problems that disqualified them from the trial, including too little tumor to create enough vaccines (4 or 5 were specified in the trial), or their GBM recurred or appeared to return. Dr. Liau attributed 12 of those 62 long-term survivors to this group, the group that supposedly had no reason to be alive. They were most likely pseudo-progressors who received DCVax-L after leaving the trial, but some may have simply lived that long with only 4 vaccines.

That's a fact.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News